EyePoint outlines mid-2026 topline data target for DURAVYU in wet AMD and DME as Phase III trials advance
EyePoint, Inc. Common Stock · LABORATORY ANALYTICAL INSTRUMENTS · Now $13.15
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS